AURORE LIFE SCIENCES, headquartered in India, is a prominent player in the pharmaceutical and biotechnology industry, specialising in innovative healthcare solutions. Founded in 2010, the company has rapidly expanded its operational footprint across major regions, including Asia and Europe, establishing itself as a trusted name in the sector. The firm focuses on the development and manufacturing of high-quality active pharmaceutical ingredients (APIs) and finished dosage forms, with a commitment to sustainability and cutting-edge technology. AURORE LIFE SCIENCES is recognised for its unique approach to product development, ensuring compliance with international standards while addressing the evolving needs of healthcare providers. With a strong market position, AURORE LIFE SCIENCES has achieved significant milestones, including partnerships with leading global pharmaceutical companies, underscoring its reputation for excellence and innovation in the life sciences arena.
How does AURORE LIFE SCIENCES's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
AURORE LIFE SCIENCES's score of 14 is lower than 91% of the industry. This can give you a sense of how well the company is doing compared to its peers.
AURORE LIFE SCIENCES, headquartered in India, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the organisation. As a result, AURORE LIFE SCIENCES has not established any significant climate commitments or initiatives to reduce its carbon footprint. The lack of emissions data and reduction strategies suggests that the company may still be in the early stages of developing its climate action framework. In the context of the broader industry, many organisations are increasingly adopting science-based targets and sustainability initiatives to mitigate climate change impacts. However, without specific commitments or data, AURORE LIFE SCIENCES's position in this regard remains unclear.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
AURORE LIFE SCIENCES has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

